CD14 and COVID-19: Particularly, the relative abundance of naïve T cells, mucosal-associated invariant T (MAIT) cells and monocyte-derived DCs decreased with the severity of COVID-19, whereas the proportions of proliferative T cells, plasma B cells, CD14+ monocytes and platelets increased with the disease severity (Zhang J. Y. et al., 2020).